Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin vs DOACs in Patients With Atrial Fibrillation and ICH
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Network Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage
JAMA Netw Open 2020 Jun 01;3(6)e206424, CT Tsai, JN Liao, CE Chiang, YJ Lin, SL Chang, LW Lo, YF Hu, TC Tuan, FP Chung, TF Chao, GYH Lip, SA ChenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.